InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Behrad Derakhshan, Chief Business Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 9 open-market SEC Form 4 transactions: 0 purchases worth $0 and 9 sales worth $1.8M, reported from May 2, 23 to Aug 12, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 25 | EWTXEdgewise Therapeutics, Inc. | SELL | 2.5K | $13.39 | $33K |
| May 2, 25 | EWTXEdgewise Therapeutics, Inc. | SELL | 1.7K | $16.45 | $28K |
| Feb 5, 25 | EWTXEdgewise Therapeutics, Inc. | SELL | 10.0K | $30.03 | $300K |
| Sep 20, 24 | EWTXEdgewise Therapeutics, Inc. | SELL | 42.1K | $29.03 | $1.2M |
| May 2, 24 | EWTXEdgewise Therapeutics, Inc. | SELL | 1.7K | $18.91 | $32K |
| Feb 9, 24 | EWTXEdgewise Therapeutics, Inc. | SELL | 4.8K | $20.04 | $96K |
| Feb 8, 24 | EWTXEdgewise Therapeutics, Inc. | SELL | 4.6K | $20.01 | $92K |
| Feb 7, 24 | EWTXEdgewise Therapeutics, Inc. | SELL | 600 | $20.00 | $12K |
| May 2, 23 | EWTXEdgewise Therapeutics, Inc. | SELL | 1.7K | $8.90 | $16K |